Ku Bo-I, Hsieh Yi-Ting, Hu Fung-Rong, Wan I-Jong, Chen Wei-Li, Hou Yu-Chih
Department of Ophthalmology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
Department of Ophthalmology, Cathay General Hospital, Taipei, Taiwan.
Taiwan J Ophthalmol. 2017 Oct-Dec;7(4):199-204. doi: 10.4103/tjo.tjo_55_17.
To compare endothelial cell density (ECD) loss rates in penetrating keratoplasty (PKP), Descemet's stripping automated endothelial keratoplasty (DSAEK), and deep anterior lamellar keratoplasty (DALK).
Single-center, multiple-surgeon, retrospective cohort study.
Patients who received PKP, DSAEK, or DALK from 2009 to 2014 were analyzed (68 vs. 38 vs. 11 patients, respectively). We excluded patients with therapeutic PKP or regraft, infection, endothelial rejection, or uncontrolled glaucoma. Only clear grafts and initial ECD more than 1000 cell/mm were included in the study. The main outcome was ECD loss rate. The follow-up time period was divided into five subgroups: 0-1.5 months, 1.5-6 months, 6-12 months, 12-24 months, and longer than 24 months.
Average ECD loss rate (cell/mm/month) declined in all three groups (PKP group: -561.5, -113.2, -36.6, -31.4, and -53.7; DSAEK group: -686.4, -68.3, -21.8, -14.4, and -5.1; DALK group: -576.5, -68, -23.7, 5.9, and 18.3). Although DSAEK group showed faster ECD loss rate in the early postoperative period, it became slower compared to the PKP group within the postoperative 6 month and demonstrated significant difference within 2 years. No ECD loss developed in the DALK group after the 1 postoperative year; this was significantly different from the PKP group.
Although ECD loss rate in the DSAEK group was initially larger than that in the PKP group, the DSAEK group possessed better long-term endothelial cell survival rate. The DALK group had a lower ECD loss rate than that of the other groups and maintained a stable ECD at 1 year after surgery.
比较穿透性角膜移植术(PKP)、Descemet膜剥脱自动内皮角膜移植术(DSAEK)和深前板层角膜移植术(DALK)中内皮细胞密度(ECD)的丢失率。
单中心、多手术医生的回顾性队列研究。
分析2009年至2014年接受PKP、DSAEK或DALK手术的患者(分别为68例、38例和11例)。我们排除了接受治疗性PKP或再次移植、感染、内皮排斥或未控制的青光眼患者。研究仅纳入植片透明且初始ECD超过1000个细胞/mm²的患者。主要观察指标为ECD丢失率。随访时间分为五个亚组:0 - 1.5个月、1.5 - 6个月、6 - 12个月、12 - 24个月和超过24个月。
所有三组的平均ECD丢失率(细胞/mm²/月)均下降(PKP组:-561.5、-113.2、-36.6、-31.4和-53.7;DSAEK组:-686.4、-68.3、-21.8、-14.4和-5.1;DALK组:-576.5、-68、-23.7、5.9和18.3)。虽然DSAEK组在术后早期显示出更快的ECD丢失率,但在术后6个月内与PKP组相比变慢,并在2年内表现出显著差异。DALK组术后1年未出现ECD丢失;这与PKP组有显著差异。
虽然DSAEK组的ECD丢失率最初高于PKP组,但DSAEK组具有更好的长期内皮细胞存活率。DALK组的ECD丢失率低于其他组,并在术后1年保持稳定的ECD。